Document ID: chunk:federal_register_of_legislation:F2021L00615:reg:7
Version: federal_register_of_legislation:F2021L00615
Segment Type: reg
Provision Reference: reg 7
Character Range: 1686–3287

7               Kind of injury, disease or death to which this Statement of Principles relates
(1)          This Statement of Principles is about porphyria cutanea tarda and death from porphyria cutanea tarda.
Meaning of porphyria cutanea tarda
(2)          For the purposes of this Statement of Principles, porphyria cutanea tarda means a skin disorder resulting from decreased activity of the enzyme uroporphyrinogen decarboxylase in the liver and accumulation of porphyrins in the circulation.
            Note: Typical clinical manifestations of porphyria cutanea tarda include blistering of the skin in sun-exposed areas, hyperpigmentation and facial hypertrichosis.
(3)          While porphyria cutanea tarda attracts ICD‑10‑AM code E80.1, in applying this Statement of Principles the meaning of porphyria cutanea tarda is that given in subsection (2).
(4)          For subsection (3), a reference to an ICD-10-AM code is a reference to the code assigned to a particular kind of injury or disease in The International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD-10-AM), Tenth Edition, effective date of 1 July 2017, copyrighted by the Independent Hospital Pricing Authority, ISBN 978-1-76007-296-4.
Death from porphyria cutanea tarda
(5)          For the purposes of this Statement of Principles, porphyria cutanea tarda, in relation to a person, includes death from a terminal event or condition that was contributed to by the person's porphyria cutanea tarda.
Note: terminal event is defined in the Schedule 1 - Dictionary.